| CTRI Number |
CTRI/2018/08/015453 [Registered on: 24/08/2018] Trial Registered Prospectively |
| Last Modified On: |
03/11/2019 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Siddha |
| Study Design |
Other |
|
Public Title of Study
|
A clinical trial to study the efficacy of Ilaguseena chooranam for Venpadai |
|
Scientific Title of Study
|
An open clinical study to evaluate the clinical efficacy of siddha sasthric formulation Ilaguseena chooranam for the treatment of venpadai |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
S Karthika |
| Designation |
PG scholar |
| Affiliation |
government siddha medical college and hospital palayamkottai |
| Address |
Government Siddha Medical College and Hospital Palayamkottai Government Siddha Medical College and Hospital Palayamkottai Tirunelveli TAMIL NADU 627002 India |
| Phone |
8939283843 |
| Fax |
|
| Email |
drkarthika1993@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
D K Soundararajan |
| Designation |
HOD |
| Affiliation |
Government siddha medical college and hospital Palayamkottai |
| Address |
Government Siddha Medical College and Hospital Palayamkottai
Government Siddha Medical College and Hospital Palayamkottai Tirunelveli TAMIL NADU 627002 India |
| Phone |
9442048801 |
| Fax |
|
| Email |
dr.dks2012@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
S Karthika |
| Designation |
PG scholar |
| Affiliation |
Government siddha medical college and hospital palayamkottai |
| Address |
Government Siddha Medical College and Hospital Palayamkottai Government Siddha Medical College and Hospital Palayamkottai Tirunelveli TAMIL NADU 627002 India |
| Phone |
8939283843 |
| Fax |
|
| Email |
drkarthika1993@gmail.com |
|
|
Source of Monetary or Material Support
|
| IPD and OPD Government Siddha Medical College and Hospital Palayamkottai
Library Government Siddha Medical College and Hospital Palayamkottai |
|
|
Primary Sponsor
|
| Name |
S karthika |
| Address |
Government siddha medical college and hospital palayamkottai |
| Type of Sponsor |
Other [PG Scholar ] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| s karthika |
Government Siddha Medical College and Hospital |
OP NO 7 Post Graduate Department of Kuzhanthai Maruthuvam Tirunelveli TAMIL NADU |
8939283843
drkarthika1993@gmail.com |
|
Details of Ethics Committee
Modification(s)
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
Modification(s)
|
| Health Type |
Condition |
| Patients |
patients suffering from venpadai, (1) ICD-10 Condition: L80||Vitiligo, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Ilagu seena chooranam |
500mg/kg/daily bid orally for 27 days |
|
|
Inclusion Criteria
|
| Age From |
2.00 Year(s) |
| Age To |
12.00 Year(s) |
| Gender |
Both |
| Details |
Hypo pigmented patches with hyper pigmented border without any structural changes in any part of the body. vitiligo present any part of the body.Patients who are willing to stay in IPD Ward for 27 days or willing to attend OPD. Children who are willing to undergo investigation and give blood and urine samples for laboratory investigation. Patient’s informant / Parent willing to sign the informed consent stating that he/she will consciously stick to the treatment during 27 days but can opt out of the trial of his / her own conscious discretion.
|
|
| ExclusionCriteria |
| Details |
Albinism
Dermatological aspect of leprosy
Tinea versicolor
Burn scars
Dermatological aspect of addisons diseases
Post inflammatory hypopigmentation
Pityriasis alba
Alopecia aerate
chemical leucoderma
white patches on mucous membrane
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
The Therapeutic Efficacy of Trial drug Ilaguseena Chooranam on Venpadai
|
27 days |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Evaluation of Siddha Diagnostic Parameters |
27 days |
|
|
Target Sample Size
|
Total Sample Size="40" Sample Size from India="40"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2 |
|
Date of First Enrollment (India)
|
27/08/2018 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="1" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
Not yet |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
|
Brief Summary
|
STUDY ENROLMENT In this study, patients reporting at the OPD with the clinical symptoms of patchy loss of skin colour. Premature whitening or graying of the hair on scalp, eye lashes, eye brows or beard. loss of colour in the tissues that lines inside the mouth,nose. Patient will be examined clinically for enrolling in the study based on inclusion and exclusion criteria.The patients who are to be enrolled patients would be informed (Form IV) about the study, trial drug, possible outcomes and the objectives of the study in the language and terms understandable to them and to their informants. After ascertaining the parent’s willingness, informed consent would be obtained in writing from them in the consent form (Form IV-A). All these patients will be given unique registration card in which patient’s registration number of the study address, phone number and Doctor’s phone number etc. will be given, So as to report easily if any complications arise. Complete clinical history, complications and duration, examination findings – all would be recorded in the prescribed proforma in the history and clinical assessment forms separately. Screening form- I will be filled up; Form I-A, Form II and Form III will be used for recording the patient’s history, clinical examination of symptoms, signs and laboratory investigations respectively. Patients would be advised to take the trial drug and appropriate dietary advice (Form IV-D) would be given according to the patient’s perfect understanding. |